EUVIMEDEUVIMED entdecken
Crossref

Quantification of the Engraftment Status of Mesenchymal Stem Cells in Glioma Using Dual-Modality Magnetic Resonance Imaging and Bioluminescence Imaging

Minghui Cao, Yunhua Li, Yingmei Tang, Meiwei Chen, Jiaji Mao, Xieqing Yang, Dongye Li, Fang Zhang, Jun Shen

Academic Radiology · 2025

DOI: 10.1016/j.acra.2024.07.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academic Radiology, 2025. Verfasst von Minghui Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Y…. Hauptthemen laut MEDLINE: Glioma, Magnetic Resonance Imaging, Mesenchymal Stem Cell Transplantation, Brain Neoplasms. Die Arbeit nennt 34 Literaturangaben. Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RATIONALE AND OBJECTIVES: The tumor-tropic properties of mesenchymal stem cells (MSCs) enable them to serve as appealing cellular vehicles for delivering therapeutic agents to treat malignant glioma. However, the exact engraftment status of MSCs in glioma via different administration routes remains unclear due to the lack of quantitative analysis. This study aimed to quantify the engraftment of MSCs in glioma after administration via different routes using non-invasive dual-modality magnetic resonance imaging (MRI) and bioluminescence imaging (BLI). MATERIALS AND METHODS: MSCs were transduced with a lentivirus overexpressing ferritin heavy chain (FTH) and firefly luciferase (FLUC) reporter genes to yield FTH- and FLUC-overexpressed MSCs (FTH-FLUC-MSCs). Wistar rats bearing intracranial C6 glioma received peritumoral, intratumoral, intra-arterial, and intravenous injection of FTH-FLUC-MSCs, respectively. MRI and BLI were performed to monitor FTH-FLUC-MSCs in vivo. RESULTS: FTH-FLUC-MSCs administered via peritumoral, intratumoral and intra-arterial routes migrated specially toward the intracranial glioma in vivo, as detected by MRI and BLI. As quantified by the BLI signal intensity, the percentages of FTH-FLUC-MSCs in the glioma were significantly higher with peritumoral injection (61%) and intratumoral injection (71%) compared to intra-arterial injection (30%) and intravenous injection (0%). Peritumorally injected FTH-FLUC-MSCs showed a gradual decline, with approximately 6% of FTH-FLUC-MSCs still retained within the tumor up to 11 days after injection. Meanwhile, the number of FTH-FLUC-MSCs injected via other routes dropped quickly, and none were detectable by day 11 post-injection. CONCLUSION: Peritumoral delivery of FTH-FLUC-MSCs offers robust engraftment and could be used as the optimal delivery route for treating malignant glioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaMagnetic Resonance ImagingMesenchymal Stem Cell TransplantationBrain NeoplasmsLuminescent MeasurementsMesenchymal Stem CellsAnimalsRatsRats, WistarMultimodal ImagingCell Line, TumorMale

Stichwörter der Autor:innen

Bioluminescence imagingMagnetic resonance imagingMalignant gliomaMesenchymal stem cellsReporter gene

Autor:innen und Institutionen

  • Department of Radiology, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, No. 107 Yanjiang Road West, Guangzhou 510120, China.
  • Department of Radiology, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, No. 107 Yanjiang Road West, Guangzhou 510120, China…

Förderung

  • National Key Research and Development Program of China Stem Cell and Translational Research
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Guangdong Provincial Natural Science Foundation

Zitieren

APA

Cao, M., Li, Y., Tang, Y., Chen, M., Mao, J., Yang, X., Li, D., Zhang, F., & Shen, J. (2025). Quantification of the Engraftment Status of Mesenchymal Stem Cells in Glioma Using Dual-Modality Magnetic Resonance Imaging and Bioluminescence Imaging. Academic Radiology. https://doi.org/10.1016/j.acra.2024.07.008

Vancouver

Cao M, Li Y, Tang Y, Chen M, Mao J, Yang X, et al. Quantification of the Engraftment Status of Mesenchymal Stem Cells in Glioma Using Dual-Modality Magnetic Resonance Imaging and Bioluminescence Imaging. Academic Radiology. 2025. doi:10.1016/j.acra.2024.07.008

BibTeX
@article{Cao2025,
  author = {Cao, Minghui and Li, Yunhua and Tang, Yingmei and Chen, Meiwei and Mao, Jiaji and Yang, Xieqing and Li, Dongye and Zhang, Fang and Shen, Jun},
  title = {Quantification of the Engraftment Status of Mesenchymal Stem Cells in Glioma Using Dual-Modality Magnetic Resonance Imaging and Bioluminescence Imaging},
  journal = {Academic Radiology},
  year = {2025},
  doi = {10.1016/j.acra.2024.07.008}
}
Kostenlos starten →